Supreme Court Chief Justice Denies Teva’s Request for an Injunction Relating to Generic Copaxone®; Clears Legal Hurdle for Mylan to Launch at Market Formation

Supreme Court Chief Justice Denies Teva’s Request for an Injunction Relating to Generic Copaxone®; Clears Legal Hurdle for Mylan to Launch at Market Formation

[PR Newswire] – PITTSBURGH, April 18, 2014 /PRNewswire/ — Mylan Inc. (MYL) today announced that Supreme Court Chief Justice Roberts has denied Teva’s application for an injunction seeking to prevent Mylan’s launch of a generic version of Copaxone® pend more

View todays social media effects on MYL

View the latest stocks trending across Twitter. Click to view dashboard

See who Mylan is hiring next, click here to view

Share this post

Comments (0)